Sun Pharma Q1 Results: PAT dips 2% YoY to Rs 2,023 cr on one-time expense
Sun Pharmaceutical on Thursday reported a nearly 2% year-on-year (YoY) drop in consolidated net profit for the quarter ended June 2023 to Rs 2,023 crore. Revenue from operations increased nearly 11% on year to Rs 11,941 crore. The fall in the bottomline was partly due to certain one-time charges totalling Rs 323 crore.
Read more on
02:24- 02:46
- 02:05
- 05:33
- 05:11
- 01:59
- 07:30
- 07:10
- 05:27
- 01:03
- 03:18
- 00:50
- 02:31
- 04:19
- 03:31
- 01:24
- 02:01
- 02:52
- 02:10
- 01:04
- 05:15
- 02:53
- 01:51
- 03:32
- 01:38
- 01:08
- 00:47
- 02:36
- 05:10
- 03:11
- 02:15
- 02:41
- 01:55
- 03:06
- 04:38
- 02:20
- 01:29
- 01:11
- 00:57
- 01:16
Related Videos
